We are live on ! Find out more
ACM

Arlington Capital Management Portfolio holdings

AUM $161M
1-Year Est. Return 38.38%
This Fund
S&P 500
This Quarter Est. Return
+12.03%
1 Year Est. Return
+38.38%
3 Year Est. Return
+153.55%
5 Year Est. Return
+294.8%
10 Year Est. Return
+509.37%
AUM
$82.6M
AUM Growth
-$66.7M
Cap. Flow
-$69M
Cap. Flow %
-83.52%
Top 10 Hldgs %
99.11%
Holding
37
New
10
Increased
Reduced
1
Closed
25

Sector Composition

Rank Sector Weight
1 Miscellaneous 97.26%
2 Financials 2.74%
3 Consumer Discretionary 0%
4 Healthcare 0%
5 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DOG
1
ProShares Short Dow30
DOG
$120M
$20.8M 25.13%
+211,777
New +$20M
EUM icon
2
ProShares Trust Short MSCI Emerging Markets
EUM
$13.2M
$14.1M 17.06%
+235,746
New +$13.3M
RWM icon
3
ProShares Short Russell2000
RWM
$149M
$13.7M 16.64%
+211,328
New +$12.8M
DDG
4
DELISTED
Proshares Short Oil & Gas
DDG
$9.86M 11.94%
+309,070
New +$9.12M
DNO
5
DELISTED
United States Short Oil Fund
DNO
$9.31M 11.27%
+145,882
New +$9.31M
AGZ icon
6
iShares Agency Bond ETF
AGZ
$634M
$3.48M 4.22%
+30,562
New +$3.47M
ISTB icon
7
iShares Core 1-5 Year USD Bond ETF
ISTB
$5.09B
$3.39M 4.1%
+67,496
New +$3.38M
GVI icon
8
iShares Intermediate Government/Credit Bond ETF
GVI
$3.75B
$3.31M 4.01%
+29,814
New +$3.3M
NIO
9
DELISTED
NUVEEN MUNICIPAL OPPORTUNITY FUND INC
NIO
$2.27M 2.74%
+160,830
New +$2.23M
WFC.PRL icon
10
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.43B
$1.65M 2%
+1,413
New +$1.67M
IBB icon
11
iShares Biotechnology ETF
IBB
$10.4B
$526K 0.64%
5,199
-174,993
-97% -$21M
PGX icon
12
Invesco Preferred ETF
PGX
$3.65B
$209K 0.25%
14,303
AAPL icon
13
Apple
AAPL
$4.86T
-7,316
Closed -$229K
AMGN icon
14
Amgen
AMGN
$206B
-20,665
Closed -$3.2M
ASHR icon
15
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.51B
-447,379
Closed -$19.5M
BAC.PRL icon
16
Bank of America Series L
BAC.PRL
$3.9B
-1,216
Closed -$1.35M
BBVA icon
17
Banco Bilbao Vizcaya Argentaria
BBVA
$161B
-111,452
Closed -$1.05M
BBWI icon
18
Bath & Body Works
BBWI
$3.61B
-128,110
Closed -$8.94M
BMRN icon
19
BioMarin Pharmaceuticals
BMRN
$12.9B
-50,369
Closed -$6.98M
BSAC icon
20
Banco Santander Chile
BSAC
$16.4B
-102,239
Closed -$717K
CII icon
21
BlackRock Enhanced Captial and Income Fund
CII
$1.05B
-56,230
Closed -$825K
IHF icon
22
iShares US Healthcare Providers ETF
IHF
$1.33B
-620,270
Closed -$17.9M
INDY icon
23
iShares S&P India Nifty 50 Index Fund
INDY
$537M
-472,551
Closed -$14.3M
IYT icon
24
iShares US Transportation ETF
IYT
$2.12B
-377,736
Closed -$13.8M
JMM icon
25
Nuveen Multi-Market Income Fund
JMM
$52.9M
-24,788
Closed -$179K

Similar funds

Arlington Capital Management's Q3 2015 Portfolio in Review

As of Q3 2015, Arlington Capital Management held 37 positions worth $82.6M, down 45% from $149M the previous quarter. Its ten largest holdings account for 99% of the portfolio.

Arlington Capital Management withdrew a net $69M in Q3 2015, closing 25 positions and reducing 1 holding. Its most notable exit was Xtrackers Harvest CSI 300 China A-Shares ETF, an estimated $19.5M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 97% of assets, up from 65% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Arlington Capital Management opened a new position in ProShares Short Dow30 worth $20.8M.

  • Arlington Capital Management's largest Q3 2015 buy was ProShares Short Dow30: 211,777 shares worth $20.8M.
  • Arlington Capital Management's biggest Q3 2015 reduction was iShares Biotechnology ETF, cutting an estimated $21M.
  • Arlington Capital Management fully exited Xtrackers Harvest CSI 300 China A-Shares ETF in Q3 2015, selling an estimated $19.5M.
  • Arlington Capital Management's ten largest holdings make up 99% of its $82.6M portfolio in Q3 2015.
  • Arlington Capital Management opened 10 new positions and closed 25 in Q3 2015.
  • Arlington Capital Management's portfolio value fell 45% quarter-over-quarter to $82.6M.

Based on Arlington Capital Management's 13F filing for Q3 2015, filed 12 Nov 2015.